AAAAAA

   
Results: 1-10 |
Results: 10
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial
Authors: Hayman, JA Martel, MK Ten Haken, RK Normolle, DP Todd, RF Littles, JF Sullivan, MA Possert, PW Turrisi, AT Lichter, AS
Citation: Ja. Hayman et al., Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial, J CL ONCOL, 19(1), 2001, pp. 127-136
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin - etoposide and daily thoracic radiotherapy in limitedsmall-cell lung cancer
Authors: Thomas, CR Giroux, DJ Janaki, LM Turrisi, AT Crowley, JJ Taylor, SA McCracken, JD Giri, PGS Gordon, W Livingston, RB Gandara, DR
Citation: Cr. Thomas et al., Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin - etoposide and daily thoracic radiotherapy in limitedsmall-cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 213-219
Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation
Authors: Williams, TE Thomas, CR Turrisi, AT
Citation: Te. Williams et al., Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation, SEM RAD ONC, 10(4), 2000, pp. 315-323
Photodynamic therapy in lung cancer - The article reviewed
Authors: Turrisi, AT
Citation: At. Turrisi, Photodynamic therapy in lung cancer - The article reviewed, ONCOLOGY-NY, 14(3), 2000, pp. 392
Limited small-cell lung cancer: A potentially curable disease
Authors: Sherman, CA Lima, CMR Turrisi, AT
Citation: Ca. Sherman et al., Limited small-cell lung cancer: A potentially curable disease, ONCOLOGY-NY, 14(10), 2000, pp. 1395-1403
Similar outcome of elderly patients in intergroup trial 0096 - Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma
Authors: Yuen, AR Zou, GY Turrisi, AT Sause, W Komaki, R Wagner, H Aisner, SC Livingston, RB Blum, R Johnson, DH
Citation: Ar. Yuen et al., Similar outcome of elderly patients in intergroup trial 0096 - Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma, CANCER, 89(9), 2000, pp. 1953-1960
Surgery versus radiation therapy for patients with aggressive fibromatosisor desmoid tumors - A comparative review of 22 articles
Authors: Nuyttens, JJ Rust, PF Thomas, CR Turrisi, AT
Citation: Jj. Nuyttens et al., Surgery versus radiation therapy for patients with aggressive fibromatosisor desmoid tumors - A comparative review of 22 articles, CANCER, 88(7), 2000, pp. 1517-1523
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
Authors: Martel, MK Ten Haken, RK Hazuka, MB Kessler, ML Strawderman, M Turrisi, AT Lawrence, TS Fraass, BA Lichter, AS
Citation: Mk. Martel et al., Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients, LUNG CANC, 24(1), 1999, pp. 31-37
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
Authors: Turrisi, AT Kim, K Blum, R Sause, WT Livingston, RB Komaki, R Wagner, H Aisner, S Johnson, DH
Citation: At. Turrisi et al., Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide, N ENG J MED, 340(4), 1999, pp. 265-271
Radiotherapy for small-cell lung cancer - reply
Authors: Turrisi, AT Kim, K Johnson, DH
Citation: At. Turrisi et al., Radiotherapy for small-cell lung cancer - reply, N ENG J MED, 340(25), 1999, pp. 2003-2004
Risultati: 1-10 |